Burst Technology

Burst Diagnostics is a medical technology company specializing in ultra-sensitive, rapid antigen testing through its proprietary Burst platform. The company's technology utilizes capillary-driven microfluidics to automate complex laboratory-grade immunoassay steps within a simple, handheld device, delivering results in minutes. By achieving sensitivity levels comparable to central lab tests at the point of care, Burst Diagnostics aims to bridge the gap between rapid testing convenience and molecular testing accuracy. Their initial product focus includes respiratory panels for COVID-19, Flu A/B, and RSV, targeting both clinical and over-the-counter markets.